A drug discovery company dedicated to developing treatments for Neurofibromatosis Type 1

INFIXION TEAM

Core Team

Herb Sarnoff, BS/MBA
Founder & CEO, NF1 Parent
Michelle Mattson-Hoss, PhD
Principal Scientist, Lead PI
Glenn Croston, PhD
Drug Discovery Consultant
Michael ‘Mick’ Frost, MD
Research Consultant, NF1 Parent
Geno Sesate
Lab Technician I
Sara Brebbia Dirksen, MS
Clinical Trial Consultant, NF1 Parent

SCIENTIFIC ADVISORY BOARD

NF1 Thought Leaders

Bob Kesterson, PhD
Univ. Alabama Birmingham
David Viskochil, MD/PhD
University Utah
Bruce Korf, MD/PhD
Univ. Alabama Birmingham
Kaleb Yohay, MD/PhD
New York University

SCIENTIFIC ADVISORY BOARD

Academic / Research Leaders

Gregory Way, PhD
University of Colorado, Anschutz
Machine Learning; Data Science
Evan Snyder, MD/PhD
Sanford Burnham, San Diego
Stem Cells; Regenerative Medicine
Shannon Lauberth, PhD
Northwestern Univ., Chicago
Molecular Genetics
James Kadonaga, PhD
UC San Diego
Transcriptional Regulation; Chromatin
Taher Sathaliya, PhD
Janssen Pharmaceuticals
Commercial Drug Development; Biomarkers

Collaborating partners

Antibody Development

Antibodies/Protein Expression

Assay Development/Screening

Reagent Development

Compound Library

Legal partners